Lessons Learned From Recent HTA Rulings on Diabetes Treatments in Australia

Presenter: Jianming He, Johnson & Johnson

Abstract

Jianming He, MA, MEDev, M.Eng is a manager of health economics at Johnson & Johnson Pharmaceutical Services, LLC. He has been working in economics for more than 15 years. Before joining JNJ, he worked as a consulatant in Pharmaceutical economics. From 1995 to 1999, he was a section chief at the State Commission for Economic Systems Restructuring, State Council of China. His current research interests are primarily in health economics of metabolic diseases and statistical modeling. Jianming He received a Master of Economics of Development from the Australian National University, a Master of Economics from University of New Hampshire, and a Master of Engineering from the Institute of Systems Sciences, the Chinese Academy of Sciences.